Cargando…
Fc Receptor-Mediated Phagocytosis in Tissues as a Potent Mechanism for Preventive and Therapeutic HIV Vaccine Strategies
While the development of a protective HIV vaccine is the ultimate goal of HIV research, to date only one HIV vaccine trial, the RV144, has successfully induced a protective response. The 31% protection from infection achieved in the RV144 trial was linked to the induction of non-neutralizing antibod...
Autores principales: | Sips, Magdalena, Krykbaeva, Marina, Diefenbach, Thomas J., Ghebremichael, Musie, Bowman, Brittany A., Dugast, Anne-Sophie, Boesch, Austin W., Streeck, Hendrik, Kwon, Douglas S., Ackerman, Margaret E., Suscovich, Todd J., Brouckaert, Peter, Schacker, Timothy W., Alter, Galit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4988947/ https://www.ncbi.nlm.nih.gov/pubmed/26883728 http://dx.doi.org/10.1038/mi.2016.12 |
Ejemplares similares
-
Lack of Protection following Passive Transfer of Polyclonal Highly Functional Low-Dose Non-Neutralizing Antibodies
por: Dugast, Anne-Sophie, et al.
Publicado: (2014) -
Altered distribution of mucosal NK cells during HIV infection
por: Sips, Magdalena, et al.
Publicado: (2011) -
Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement
por: Lofano, Giuseppe, et al.
Publicado: (2018) -
A versatile high-throughput assay to characterize antibody-mediated neutrophil phagocytosis
por: Karsten, Christina B., et al.
Publicado: (2019) -
Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles
por: Brown, Eric P., et al.
Publicado: (2017)